Search - tctmd.com

Displaying 381 - 400 of 685

Sort: Relevancy | Date

Presentation TCT 2017

Making the EHR Useful For Research: ADAPTABLE

Presenter: Ori Ben-Yehuda, Robert A. Harrington, Roxana Mehran, Adrian F Hernandez

October 30, 2017

Presentation TCT 2017

Getting Surgical-like Results With Alcohol Septal Ablation

Presenter: Carey D. Kimmelstiel, Richard Smalling, Paul Sorajja

October 30, 2017

Presentation TCT 2017

Keeping It Simple: Large Pragmatic Trials

Presenter: Ori Ben-Yehuda, Robert A. Harrington, Roxana Mehran

October 30, 2017

Presentation TCT 2017

Alcohol Septal Ablation - Learning Techniques Through Proctoring

Presenter: Carey D. Kimmelstiel, Richard Smalling, Srihari S. Naidu

October 30, 2017

Presentation TCT 2017

Building an HCM Program - Benchmarks for Centers of Excellence

Presenter: Carey D. Kimmelstiel, Richard Smalling, Sherif F. Nagueh

October 30, 2017

Presentation TCT 2017

The Inflammatory Hypothesis After CANTOS: CIRT

Presenter: Bernard J. Gersh, Robert A. Harrington, Wolfgang Koenig

October 30, 2017

Presentation TCT 2017

Can Alcohol Ablation Be Used to Treat Ventricular Tachycardia?

Presenter: John S. Douglas Jr, Valerian Fernandes, Vivek Y. Reddy

October 30, 2017

Presentation TCT 2017

The LDL Hypothesis Post FOURIER: Heading Home From ODYSSEY

Presenter: Bernard J. Gersh, Robert A. Harrington, Wolfgang Koenig

October 30, 2017

Presentation TCT 2017

High-grade AV Block After ASA

Presenter: John S. Douglas Jr, Valerian Fernandes

October 30, 2017

Presentation TCT 2017

Might Mitraclip Make Ablation Irrelevant?

Presenter: John S. Douglas Jr, Valerian Fernandes, Paul Sorajja

October 30, 2017

Presentation TCT 2017

Should Alleviating ISCHEMIA Be the Goal?

Presenter: Bernard J. Gersh, Robert A. Harrington, David J. Moliterno

October 30, 2017

Presentation TCT 2017

Evaluation and Management of AS With Obstructive HCM

Presenter: John S. Douglas Jr, Valerian Fernandes, Srihari S. Naidu

October 30, 2017

Presentation TCT 2017

Primary Prevention in High Risk Patients II: THEMIS

Presenter: Bernard J. Gersh, Robert A. Harrington

October 30, 2017

Presentation TCT 2017

Primary Prevention In High Risk Patients I: REPRIEVE

Presenter: Bernard J. Gersh, Robert A. Harrington, Pamela S. Douglas

October 30, 2017

Presentation TCT 2017

When to Declare Victory

Presenter: John S. Douglas Jr, Valerian Fernandes, Christopher D. Nielsen

October 30, 2017

Presentation TCT 2017

My Worst Complication(s)

Presenter: John S. Douglas Jr, Valerian Fernandes, George S. Hanzel

October 30, 2017

Presentation TCT 2017

My Most Difficult Case(s)

Presenter: John S. Douglas Jr, Valerian Fernandes

October 30, 2017

Presentation TCT 2017

Predicting The Future: Will the Ongoing COAPT Trial Change How We Treat Patients With Secondary MR in Heart Failure?

Presenter: David H. Adams, Ted Feldman, Gilles Dreyfus

October 30, 2017

Presentation TCT 2017

Predicting the Future: Will the Ongoing TAVR UNLOAD and Early TAVR Trials Change the Threshold for TAVR in Moderate and Asymptomatic Aortic Stenosis?

Presenter: David H. Adams, Ted Feldman, Allan Schwartz

October 30, 2017

Presentation TCT 2017

Is Ventricular Arrhythmia After Ablation a Real Phenomenon?

Presenter: Srihari S. Naidu, Paul Sorajja, George S. Hanzel

October 30, 2017

Advertisement

Making the EHR Useful For Research: ADAPTABLE

Getting Surgical-like Results With Alcohol Septal Ablation

Keeping It Simple: Large Pragmatic Trials

Alcohol Septal Ablation - Learning Techniques Through Proctoring

Building an HCM Program - Benchmarks for Centers of Excellence

The Inflammatory Hypothesis After CANTOS: CIRT

Can Alcohol Ablation Be Used to Treat Ventricular Tachycardia?

The LDL Hypothesis Post FOURIER: Heading Home From ODYSSEY

High-grade AV Block After ASA

Might Mitraclip Make Ablation Irrelevant?

Should Alleviating ISCHEMIA Be the Goal?

Evaluation and Management of AS With Obstructive HCM

Primary Prevention in High Risk Patients II: THEMIS

Primary Prevention In High Risk Patients I: REPRIEVE

When to Declare Victory

My Worst Complication(s)

My Most Difficult Case(s)

Predicting The Future: Will the Ongoing COAPT Trial Change How We Treat Patients With Secondary MR in Heart Failure?

Predicting the Future: Will the Ongoing TAVR UNLOAD and Early TAVR Trials Change the Threshold for TAVR in Moderate and Asymptomatic Aortic Stenosis?

Is Ventricular Arrhythmia After Ablation a Real Phenomenon?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content